Literature DB >> 3604456

Molecular cloning and nucleotide sequence of P, M and F genes of Newcastle disease virus avirulent strain D26.

H Sato, M Oh-hira, N Ishida, Y Imamura, S Hattori, M Kawakita.   

Abstract

Molecular cloning of most if not all of the genome of an avirulent strain D26 of Newcastle disease virus (NDV) was carried out. cDNA clones were aligned by mutual hybridization and restriction map analysis. The nucleotide sequence of 3672 bases which completed the partial sequence of P gene reported in our previous paper (Ishida, N. et al., 1986, Nucleic Acids Res. 14, 6551-6564), and also covered M and F genes, was determined. Each gene contained one long open reading frame which could code for polypeptides of 395, 364, and 553 amino acid residues, respectively. The deduced amino acid sequences of P and M gene products showed little homology to those of other paramyxoviruses. In contrast, comparison of the amino acid sequence of the F gene product revealed highly conserved regions including the amino terminal sequence of the F1 portion following the putative processing site. There was only one basic amino acid residue at the putative processing site, which would explain the low virulence of this strain.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3604456     DOI: 10.1016/0168-1702(87)90031-1

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  18 in total

1.  Development of an effective polyvalent vaccine against both Marek's and Newcastle diseases based on recombinant Marek's disease virus type 1 in commercial chickens with maternal antibodies.

Authors:  K Sonoda; M Sakaguchi; H Okamura; K Yokogawa; E Tokunaga; S Tokiyoshi; Y Kawaguchi; K Hirai
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

2.  Editing of the Sendai virus P/C mRNA by G insertion occurs during mRNA synthesis via a virus-encoded activity.

Authors:  S Vidal; J Curran; D Kolakofsky
Journal:  J Virol       Date:  1990-01       Impact factor: 5.103

3.  Nucleotide sequence of the phosphoprotein (P) gene of Newcastle disease virus (strain Beaudette C).

Authors:  S Daskalakis; J Menke; B Stripp; H Stone
Journal:  Nucleic Acids Res       Date:  1992-02-11       Impact factor: 16.971

4.  RNA editing by G-nucleotide insertion in mumps virus P-gene mRNA transcripts.

Authors:  R G Paterson; R A Lamb
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

5.  Identification of amino acids relevant to three antigenic determinants on the fusion protein of Newcastle disease virus that are involved in fusion inhibition and neutralization.

Authors:  T Toyoda; B Gotoh; T Sakaguchi; H Kida; Y Nagai
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

6.  Mutations located on both F1 and F2 subunits of the Newcastle disease virus fusion protein confer resistance to neutralization with monoclonal antibodies.

Authors:  C Neyt; J Geliebter; M Slaoui; D Morales; G Meulemans; A Burny
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

7.  Nucleotide sequence of cDNA to the rinderpest virus mRNA encoding the nucleocapsid protein.

Authors:  H Kamata; K Tsukiyama; M Sugiyama; Y Kamata; Y Yoshikawa; K Yamanouchi
Journal:  Virus Genes       Date:  1991-01       Impact factor: 2.332

8.  Pathogenicity and phylogenetic evaluation of the variant Newcastle disease viruses termed "pigeon PMV-1 viruses" based on the nucleotide sequence of the fusion protein gene.

Authors:  M S Collins; I Strong; D J Alexander
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

9.  Analysis of matrix protein gene nucleotide sequence diversity among Newcastle disease virus isolates demonstrates that recent disease outbreaks are caused by viruses of psittacine origin.

Authors:  B S Seal
Journal:  Virus Genes       Date:  1995       Impact factor: 2.332

10.  Antiviral action of interferon-beta on Newcastle disease virus: selectivity to the hemagglutinin-neuraminidase gene expression.

Authors:  Z Yu; B Gotoh; M Hamaguchi; Y Nagai
Journal:  Med Microbiol Immunol       Date:  1995-05       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.